||Recombinant human MYOZ2 (264 aa) protein fused with T7 Tag at N-terminal was expressed in E. coli.
||0.2 mg/ml, sterile-filtered, in 20 mM pH 8.0 Tris-HCl Buffer, with proprietary formulation of NaCl, KCl, EDTA, arginine, DTT and Glycerol.
||MASMTGGQQMGRGEFMLSHNTMMKQRKQQATAIMKEVHGNDVDGMDLGKKVSIPRDIMLEELSHLSNRGARLFKM RQRRSDKYTFENFQYQSRAQINHSIAMQNGKVDGSNLEGGSQQAPLTPPNTPDPRSPPNPDNIAPGYSGPLKEIP PEKFNTTAVPKYYQSPWEQAISNDPELLEALYPKLFKPEGKAELPDYRSFNRVATPFGGFEKASRMVKFKVPDFE LLLLTDPRFMSFVNPLSGRRSFNRTPKGWISENIPIVITTEPTDDTTVPESEDL
||>90% by SDS-PAGE
||1. May be used for in vitro calcium-dependent signal transduction pathway regulation study for cardiomyocytes with intracellular delivery of this protein.2. As soluble / native protein, may be used as enzymatic substrate protein for kinase and ubiquitin assay development.3. May be used for mapping MYOZ2 protein-protein interaction.4. Potential biomarker protein for monitoring human cardiomyocytes damage in various diseases.5. May be used as antigen for specific antibody development.
||Keep at -80°C for long term storage. Product is stable at 4 °C for at least 30 days.